Connection

Michael Rose to Mutation

Back to Details
This is a "connection" page, showing publications Michael Rose has written about Mutation.
Michael Rose
Connection Strength
0.375
Mutation
  1. Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget. 2016 Nov 01; 7(44):71429-71439.
    View in: PubMed
    Score: 0.095
  2. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology. 2012 Sep 11; 79(11):1145-54.
    View in: PubMed
    Score: 0.071
  3. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2010 Mar; 20(3):166-73.
    View in: PubMed
    Score: 0.059
  4. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007 Aug; 130(Pt 8):2024-36.
    View in: PubMed
    Score: 0.049
  5. Do longevity mutants always show trade-offs? Exp Gerontol. 2006 Oct; 41(10):1055-8.
    View in: PubMed
    Score: 0.046
  6. Pharmacology, genomics, and the evolutionary biology of ageing. Free Radic Res. 2002 Dec; 36(12):1293-7.
    View in: PubMed
    Score: 0.036
  7. Laboratory selection quickly erases historical differentiation. PLoS One. 2014; 9(5):e96227.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.